Long‐term outcomes in breast cancer patients undergoing immediate 2‐stage expander/implant reconstruction and postmastectomy radiation
Authors:
- Alice HoAHAlice Ho
- Kimberly J. Van ZeeKZKimberly J. Van Zee
- Amanda McLaneAMAmanda McLane
- Beryl McCormickBMBeryl McCormick
Open Access
- 14 September 2011
- Vol. 118 (9) , 2552-2559
Abstract
BACKGROUND: Breast reconstruction with tissue expander (TE)/permanent implant (PI) followed by postmastectomy radiation (PMRT) is an increasingly popular treatment for breast cancer patients. The long‐term rates of permanent implant removal or replacement (PIRR) and clinical outcomes in patients treated with a uniform reconstructive surgery and radiation regimen were evaluated.METHODS: Between 1996 and 2006, 1639 patients with stage II‐III breast cancer received modified radical mastectomy (MRM) at Memorial Sloan‐Kettering Cancer Center. A total of 751 received TE placement at the time of mastectomy. Of these, 151 patients went on to receive chemotherapy and exchange of the TE for a permanent implant, followed by PMRT. Clinical outcomes and PIRR‐free rates were estimated by Kaplan‐Meier methods. Cox regression model was used to examine patient, disease, and treatment characteristics associated with PIRR.RESULTS: Median follow‐up was 86 months (range, 11‐161 months). The 7‐year PIRR‐free rate was 71% (38 PIRRs in 35 patients). The 7‐year rate of PI replacement was 17.1% (21), and removal was 13.3% (17). Reasons for PIRR included infection (15); implant extrusion, shift, leak, or rupture (4); patient request (1), or multifactorial (17). On univariate analysis, no factor was significantly associated with PIRR. Two patients experienced local recurrence in the chest wall, both after 7 years. The 7‐year distant metastasis–free survival rate was 81% and overall survival 93%.CONCLUSIONS: Favorable 7‐year PIRR rates and clinical outcomes were achieved in a sizable cohort of patients treated with homogeneous sequencing, radiation, and reconstructive surgery and lengthy follow‐up. Factors predictive for high risk of PIRR were not identifiable in this population. Cancer 2012. © 2011 American Cancer Society.Keywords
This publication has 20 references indexed in Scilit:
- Impact of Sequencing of Postmastectomy Radiotherapy and Breast Reconstruction on Timing and Rate of Complications and Patient SatisfactionInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Patient-Reported Aesthetic Satisfaction with Breast Reconstruction during the Long-Term Survivorship PerioPlastic and Reconstructive Surgery, 2009
- Incidence of severe capsular contracture following implant-based immediate breast reconstruction with or without postoperative chest wall radiotherapy using 40 Gray in 15 fractionsRadiotherapy and Oncology, 2009
- Clinical Outcomes of Postmastectomy Radiation Therapy After Immediate Breast ReconstructionInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- Prospective Analysis of Long-term Psychosocial Outcomes in Breast ReconstructionAnnals of Surgery, 2008
- The Impact of Breast Reconstruction on the Oncologic Efficacy of Radiation TherapyAnnals of Plastic Surgery, 2008
- Mastectomy With Immediate Expander-Implant Reconstruction, Adjuvant Chemotherapy, and Radiation for Stage II–III Breast Cancer: Treatment Intervals and Clinical OutcomesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2008
- A Single Surgeon???s 12-Year Experience with Tissue Expander/Implant Breast Reconstruction: Part I. A Prospective Analysis of Early ComplicationsPlastic and Reconstructive Surgery, 2006
- Implant Reconstruction in Breast Cancer Patients Treated with Radiation TherapyPlastic and Reconstructive Surgery, 2006
- Low complication rates are achievable after postmastectomy breast reconstruction and radiation therapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004